ABSTRACT

Ethylene vinyl acetate (EVA) has a long and successful history of innovation in medical packaging, medical devices, and pharmaceutical applications. In fact, EVA has been an innovative force in those applications for over 35 years and continues its innovation legacy through enablement of solutions in areas of ever increasing challenges. New solutions are required for continually improving patient healthcare. This paper will examine the evolutionary role of EVA innovation in diverse applications ranging from its early use in parenteral applications for delivery of life saving medications to cryogenic storage bags for stem cells used in the emerging field of cell therapy to controlled release of small molecule active pharmaceutical ingredients (API) and finally as an innovative gastroretentive delivery vehicle for controlled release of large molecule therapeutics for the high growth field of biologics and personalized medicine. It is the simplicity of the molecular architecture of EVA which leads to its ability to create innovative solutions to some of healthcare’s most challenging and complex problems. Case studies will provide an illustration of each of these applications.

See Celanese Information